Endeavour Vision is a leading private equity firm, focused exclusively on supporting growth-stage medtech companies. Our mission is to transform the standard of care for millions of patients by investing in groundbreaking medical innovations. Endeavour Vision’s team offers unmatched sector and operational expertise, extensive international experience including product launches and accelerating company growth, in addition to a proven track record of successful exits. The firm's recent investments include Relievant, Medartis (IPO in 2018), Vertiflex (acquired by Boston Scientific in 2019) and Symetis (acquired by Boston Scientific in 2017). The company headquarters are in Geneva, Switzerland with further presence in North America.